You are here

0 users have voted.

LVADs have been under development for nearly three decades, but only in recent years has the technology advanced enough to allow patients to actually go home with an LVAD. As the technology has continued to improve, LVADs have become a more favorable option for people with advanced heart failure.

Today, thousands of patients around the world receive LVADs each year. Meanwhile, researchers and device manufacturers continue to find ways to make them more durable, reliable and convenient for patients.

Then and Now

The first LVADs were called pulsatile pumps. They mimicked the way the heart works, by filling entirely with blood and then ejecting it all at once into the aorta, before filling again.(Read about what an LVAD is how it works.)

The LVADs used today are continuous flow pumps. As their name suggests, they move blood continuously from the heart into the aorta. As a result, most LVAD patients have very little if any detectable pulse, even though blood is moving through the body.

Today’s LVAD devices vary by manufacturer, each with slightly different types of engineering. Despite these differences, all continuous flow pumps have several important advantages over earlier pumps:

  • They have unique engineering designs and fewer moving parts, so they’re more durable and reliable.
  • They are smaller than earlier pumps, which mean that more patients—including people with smaller frames—are candidates to receive them.
  • They have smaller, more flexible drivelines, which helps diminish the chance of driveline infections. The earlier pulsatile pumps had drivelines with about the same diameter as a dime, but today’s continuous flow pumps have drivelines closer to the size of a pencil.

The Future of LVADs

Device manufacturers continue to improve LVAD technology with the goal of making the devices not only more reliable, but more convenient and discreet for patients. The hope is that in the future LVADs will have smaller external components including smaller drivelines, smaller controllers and longer battery life. The ultimate goal in LVAD technology, while still some years down the road, is to have all components implanted, with only an external power supply to transmit energy to an internal battery.



0 users have voted.

We look to the future while reading about Carbon Fiber Nanotube Lithium batteries that are 10 times smaller with 8 times more power.  we read of nanotube cords the size of a thread that are strong as steel and can carry power to new unheard of distances. We have high hopes for subcutaneous power systems that charge through the skin.And we know that if gene and cellular therapy do not fulfill their promise of healing damaged cardiac muscle,  providing the bridge to healing we hope for. -  then the technology will need to provide the answer!Scientists go with God!

0 users have voted.